Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Infectious Disease In Vitro Diagnostics Global Market Report 2025
Download Free Sample Buy Now
Global Infectious Disease In Vitro Diagnostics Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Infectious Disease In Vitro Diagnostics Global Market Report 2025

By Product Type (Instruments, Reagents, Software And Services), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Hematology, Urinalysis, Other Technologies), By Application (Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications), By End-Use (Hospitals And Clinics, Diagnostic Laboratories, Academic Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Infectious Disease In Vitro Diagnostics Market Overview

• Infectious Disease In Vitro Diagnostics market size has reached to $14.14 billion in 2024

• Expected to grow to $19.83 billion in 2029 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Surge In Global Prevalence Of Infectious Diseases Fueled The Market Growth Due To Increased Demand For Effective Diagnostic Solutions

• Market Trend: Developing Rapid Multi-Pathogen Detection Solutions To Enhance Timely Diagnosis And Expand Point-Of-Care Testing

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Infectious Disease In Vitro Diagnostics Market?

Infectious disease in vitro diagnostics refers to laboratory-based tests performed on samples such as blood, urine, or swabs to detect, identify, and monitor infectious pathogens, including bacteria, viruses, fungi, and parasites. These diagnostics help to provide accurate and timely diagnosis, guide treatment decisions, and support disease surveillance and infection control measures.

The main product types of infectious disease in vitro diagnostics are instruments, reagents, and software and services. Instruments refer to tools or devices used to measure and monitor environmental conditions such as air, water, soil, and noise. It utilizes various technologies such as molecular diagnostics, immunoassay, microbiology, hematology, urinalysis, and others. It finds application in methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile, respiratory virus, tuberculosis (TB) and drug-resistant TB, gonorrhea, human papillomavirus (HPV), human immunodeficiency virus (HIV), hepatitis C, hepatitis B, and others, serving end-users such as hospitals and clinics, diagnostic laboratories, academic research institutes, and others.

Infectious Disease In Vitro Diagnostics Market Size and growth rate 2025 to 2029: Graph

What Is The Infectious Disease In Vitro Diagnostics Market Size 2025 And Growth Rate?

The infectious disease in vitro diagnostics market size has grown strongly in recent years. It will grow from $14.14 billion in 2024 to $15.1 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to antibiotic resistance, globalization and travel, aging population, emergence of novel pathogens, and bioterrorism threats.

What Is The Infectious Disease In Vitro Diagnostics Market Growth Forecast?

The infectious disease in vitro diagnostics market size is expected to see strong growth in the next few years. It will grow to $19.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising demand for point-of-care testing, growing prevalence of infectious diseases, increasing adoption of personalized medicine, and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include next-generation sequencing, microfluidics-based platforms, lab-on-a-chip technology, multiplex polymerase chain reaction (PCR) assays, and digital immunoassays.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Infectious Disease In Vitro Diagnostics Market Segmented?

1) By Product Type: Instruments, Reagents, Software And Services

2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology, Hematology, Urinalysis, Other Technologies

3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications

4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Hematology Analyzers, Urinalysis Analyzers, Next Generation Sequencers, Flow Cytometers

2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Hematology Reagents, Urinalysis Reagents, Enzymes And Buffers, Controls And Calibrators

3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services, Remote Monitoring Services

What Is Driving The Infectious Disease In Vitro Diagnostics Market? Surge In Global Prevalence Of Infectious Diseases Fueled The Market Growth Due To Increased Demand For Effective Diagnostic Solutions

The increased global prevalence of infectious diseases fueled the growth of the infectious disease in vitro diagnostics market during the historic period. Infectious diseases refer to the individuals affected by bacterial, viral, fungal, or parasitic infections worldwide at a specific point in time, indicating the overall disease burden within populations. Climate change has expanded the habitats of disease-carrying vectors such as mosquitoes, leading to a rise in the global prevalence of infectious diseases. The infectious disease in vitro diagnostics support this trend by providing precise and timely diagnostic tools that enable healthcare providers to identify pathogens, initiate appropriate treatment, and contain outbreaks more effectively. For instance, in October 2024, according to the World Health Organization, a Switzerland-based health authority, approximately 10.8 million people worldwide contracted tuberculosis, with 55% being men, 33% women, and 12% children and adolescents, and individuals living with human immunodeficiency virus (HIV) representing 6.1% of cases. Therefore, the increasing global prevalence of infectious diseases fueled the growth of the infectious disease in vitro diagnostics industry during the historic period.

Who Are The Major Players In The Global Infectious Disease In Vitro Diagnostics Market?

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, BioMérieux SA, Qiagen N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Quest Diagnostics, Revvity Inc. (Formerly PerkinElmer, Inc.), OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries, Bio-Rad Laboratories Inc., Trivitron Healthcare, and InBios International Inc.

What Are The Key Trends Of The Global Infectious Disease In Vitro Diagnostics Market? Developing Rapid Multi-Pathogen Detection Solutions To Enhance Timely Diagnosis And Expand Point-Of-Care Testing

Major companies operating in the infectious disease in vitro diagnostics market are focusing on developing innovative products, such as rapid detection of multiple gastrointestinal pathogens, to enable timely diagnosis, improve patient outcomes, and expand point-of-care testing capabilities. Rapid detection of multiple gastrointestinal pathogens refers to diagnostic tests that can quickly identify the presence of several disease-causing microorganisms in the gastrointestinal tract from a single sample. For instance, in June 2024, MP Biomedicals, a US-based provider of a diverse range of products, chemicals, and diagnostics, launched a range of immunochromatographic-based rapid diagnostic kits for gastrointestinal infectious diseases. These enable quick and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. These kits feature rapid, point-of-care qualitative detection, versatile sample use (stool, blood, plasma, serum, water, and food), and suitability for both clinical and research settings. Leveraging cutting-edge immunochromatographic technology, they support early diagnosis, monitoring of treatment effectiveness, and confirmation of pathogen eradication, representing a significant advancement in gastrointestinal health diagnostics by combining speed, precision, and broad pathogen coverage.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market? Fremman Capital Acquires Majority Stake In DIESSE Diagnostica Senese To Drive International Expansion And Strengthen In Vitro Diagnostics Leadership

In January 2025, Fremman Capital, a UK-based private equity firm specializing in healthcare and life sciences investments, acquired a majority stake in DIESSE Diagnostica Senese for an undisclosed amount. With this acquisition, Fremman Capital aims to accelerate DIESSE’s international expansion and strengthen its position as a leader in the specialty in vitro diagnostics market by supporting innovation, broadening the product portfolio for autoimmune and infectious disease diagnostics, and enhancing production capacities at DIESSE’s advanced biotech campus, thereby driving long-term sustainable growth. DIESSE Diagnostica Senese is an Italy-based producer of innovative in vitro diagnostics and reagents focused on autoimmunity, infectious diseases, and hematological testing, serving clinical laboratories globally.

What Is The Regional Outlook For The Global Infectious Disease In Vitro Diagnostics Market?

North America was the largest region in the infectious disease in vitro diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Infectious Disease In Vitro Diagnostics Market?

The infectious disease in vitro diagnostics market consists of revenues earned by entities by providing services such as serology testing, rapid diagnostic testing, disease surveillance and monitoring, sample collection and processing, and consulting and training services. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease in vitro diagnostics market also includes sales of rapid test kits, culture media, controls and calibrators, molecular sequencing kits, flow cytometry reagents, and point-of-care diagnostic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Infectious Disease In Vitro Diagnostics Industry?

The infectious disease in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease in vitro diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Infectious Disease In Vitro Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $15.1 billion
Revenue Forecast In 2034 $19.83 billion
Growth Rate CAGR of 6.7% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Product Type, Technology, Application, End-Use
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, BioMérieux SA, Qiagen N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Quest Diagnostics, Revvity Inc. (Formerly PerkinElmer, Inc.), OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries, Bio-Rad Laboratories Inc., Trivitron Healthcare, and InBios International Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Infectious Disease In Vitro Diagnostics Market Characteristics

3. Infectious Disease In Vitro Diagnostics Market Trends And Strategies

4. Infectious Disease In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Infectious Disease In Vitro Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Infectious Disease In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Infectious Disease In Vitro Diagnostics Market Growth Rate Analysis

5.4. Global Infectious Disease In Vitro Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Infectious Disease In Vitro Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Infectious Disease In Vitro Diagnostics Total Addressable Market (TAM)

6. Infectious Disease In Vitro Diagnostics Market Segmentation

6.1. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Instruments

Reagents

Software And Services

6.2. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Molecular Diagnostics

Immunoassay

Microbiology

Hematology

Urinalysis

Other Technologies

6.3. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Methicillin-Resistant Staphylococcus Aureus (MRSA)

Clostridium Difficile

Respiratory Virus

Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB)

Gonorrhea

Human Papillomavirus (HPV)

Human Immunodeficiency Virus (HIV)

Hepatitis C

Hepatitis B

Other Applications

6.4. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Clinics

Diagnostic Laboratories

Academic Research Institutes

Other End-Users

6.5. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Polymerase Chain Reaction Machines

Immunoassay Analyzers

Microbiology Analyzers

Hematology Analyzers

Urinalysis Analyzers

Next Generation Sequencers

Flow Cytometers

6.6. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Molecular Reagents

Immunoassay Reagents

Microbiology Reagents

Hematology Reagents

Urinalysis Reagents

Enzymes And Buffers

Controls And Calibrators

6.7. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Management Software

Laboratory Information Systems

Cloud Based Solutions

Maintenance And Support Services

Consulting And Training Services

Remote Monitoring Services

7. Infectious Disease In Vitro Diagnostics Market Regional And Country Analysis

7.1. Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infectious Disease In Vitro Diagnostics Market

8.1. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infectious Disease In Vitro Diagnostics Market

9.1. China Infectious Disease In Vitro Diagnostics Market Overview

9.2. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infectious Disease In Vitro Diagnostics Market

10.1. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infectious Disease In Vitro Diagnostics Market

11.1. Japan Infectious Disease In Vitro Diagnostics Market Overview

11.2. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infectious Disease In Vitro Diagnostics Market

12.1. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infectious Disease In Vitro Diagnostics Market

13.1. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infectious Disease In Vitro Diagnostics Market

14.1. South Korea Infectious Disease In Vitro Diagnostics Market Overview

14.2. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infectious Disease In Vitro Diagnostics Market

15.1. Western Europe Infectious Disease In Vitro Diagnostics Market Overview

15.2. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infectious Disease In Vitro Diagnostics Market

16.1. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infectious Disease In Vitro Diagnostics Market

17.1. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infectious Disease In Vitro Diagnostics Market

18.1. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infectious Disease In Vitro Diagnostics Market

19.1. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infectious Disease In Vitro Diagnostics Market

20.1. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infectious Disease In Vitro Diagnostics Market

21.1. Eastern Europe Infectious Disease In Vitro Diagnostics Market Overview

21.2. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infectious Disease In Vitro Diagnostics Market

22.1. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infectious Disease In Vitro Diagnostics Market

23.1. North America Infectious Disease In Vitro Diagnostics Market Overview

23.2. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infectious Disease In Vitro Diagnostics Market

24.1. USA Infectious Disease In Vitro Diagnostics Market Overview

24.2. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infectious Disease In Vitro Diagnostics Market

25.1. Canada Infectious Disease In Vitro Diagnostics Market Overview

25.2. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infectious Disease In Vitro Diagnostics Market

26.1. South America Infectious Disease In Vitro Diagnostics Market Overview

26.2. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infectious Disease In Vitro Diagnostics Market

27.1. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infectious Disease In Vitro Diagnostics Market

28.1. Middle East Infectious Disease In Vitro Diagnostics Market Overview

28.2. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infectious Disease In Vitro Diagnostics Market

29.1. Africa Infectious Disease In Vitro Diagnostics Market Overview

29.2. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infectious Disease In Vitro Diagnostics Market Competitive Landscape And Company Profiles

30.1. Infectious Disease In Vitro Diagnostics Market Competitive Landscape

30.2. Infectious Disease In Vitro Diagnostics Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthcare AG Overview, Products and Services, Strategy and Financial Analysis

31. Infectious Disease In Vitro Diagnostics Market Other Major And Innovative Companies

31.1. BioMérieux SA

31.2. Qiagen N.V.

31.3. Becton

31.4. Dickinson and Company

31.5. Hologic Inc.

31.6. Labcorp Holdings Inc.

31.7. DiaSorin S.p.A.

31.8. Meridian Bioscience

31.9. Quidel Corporation

31.10. Quest Diagnostics

31.11. Revvity Inc. (Formerly PerkinElmer Inc.)

31.12. OraSure Technologies Inc.

31.13. Transasia Bio-Medicals Ltd.

31.14. Randox Laboratories

31.15. Luminex Corporation

32. Global Infectious Disease In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market

34. Recent Developments In The Infectious Disease In Vitro Diagnostics Market

35. Infectious Disease In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Infectious Disease In Vitro Diagnostics Market In 2029 - Countries Offering Most New Opportunities

35.2 Infectious Disease In Vitro Diagnostics Market In 2029 - Segments Offering Most New Opportunities

35.3 Infectious Disease In Vitro Diagnostics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: F. Hoffmann-La Roche AG Financial Performance
  • Table 79: Abbott Laboratories Financial Performance
  • Table 80: Danaher Corporation Financial Performance
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Siemens Healthcare AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: F. Hoffmann-La Roche AG Financial Performance
  • Figure 79: Abbott Laboratories Financial Performance
  • Figure 80: Danaher Corporation Financial Performance
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Siemens Healthcare AG Financial Performance

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Read More About Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the maternal and baby grade wipes market backed by expert analysis and data-driven projections.

Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Read More About Discover the latest insights, trends, and market numbers in the medical soap market backed by expert analysis and data-driven projections.

Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual biopsy market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

Read More About Explore the latest trends, growth insights, and forecasts in the Global Nuclear Reactor Market.

In Vitro Diagnostics Global Market Report 2025 – By Type (Point of Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular...

View Report

Infectious Disease Diagnostics Testing Global Market Report 2025 – By Type (Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test), By Application (Respiratory, Human Immunodeficiency ...

View Report

Veterinary Infectious Disease Diagnostics Global Market Report 2025 – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-Producing a...

View Report

In Vitro Diagnostics Enzymes Global Market Report 2025 – By Enzyme Type (Proteases, Polymerase And Transcriptase, Ribonuclease, Other Enzyme Types), By Disease Type (Infectious Disease, Diabetes, Oncology, Cardiology, Ne...

View Report

In Vitro Diagnostics (IVD) Quality Control Global Market Report 2025 – By Product type (Quality Control Products, Data Management Solutions, Quality Assurance Services), By Manufacturer Type (IVD Instrument Manufacturers...

View Report

Infectious Disease Therapeutics Global Market Report 2025 – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharmacies, Res...

View Report

Viral Diagnostic Test Kits Global Market Report 2025 – By Test (Traditional Tests, Rapid Test), By Test Type (Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Re...

View Report

Hospital Acquired Infections Testing Kits Global Market Report 2025 – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumonia Infection, Urinary Track Infection, Blood Stream Associated Infection, Sur...

View Report

Frequently Asked Questions

Infectious disease in vitro diagnostics refers to laboratory-based tests performed on samples such as blood, urine, or swabs to detect, identify, and monitor infectious pathogens, including bacteria, viruses, fungi, and parasites. These diagnostics help to provide accurate and timely diagnosis, guide treatment decisions, and support disease surveillance and infection control measures. For further insights on this market, request a sample here

The market major growth driver - Surge In Global Prevalence Of Infectious Diseases Fueled The Market Growth Due To Increased Demand For Effective Diagnostic Solutions. For further insights on this market, request a sample here

The infectious disease in vitro diagnostics market size has grown strongly in recent years. It will grow from $14.14 billion in 2024 to $15.1 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to antibiotic resistance, globalization and travel, aging population, emergence of novel pathogens, and bioterrorism threats. The infectious disease in vitro diagnostics market size is expected to see strong growth in the next few years. It will grow to $19.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to rising demand for point-of-care testing, growing prevalence of infectious diseases, increasing adoption of personalized medicine, and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include next-generation sequencing, microfluidics-based platforms, lab-on-a-chip technology, multiplex polymerase chain reaction (PCR) assays, and digital immunoassays. For further insights on this market, request a sample here

The infectious disease in vitro diagnostics market covered in this report is segmented –
1) By Product Type: Instruments, Reagents, Software And Services
2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology, Hematology, Urinalysis, Other Technologies
3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications
4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Academic Research Institutes, Other End-Users Subsegments:
1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Hematology Analyzers, Urinalysis Analyzers, Next Generation Sequencers, Flow Cytometers
2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Hematology Reagents, Urinalysis Reagents, Enzymes And Buffers, Controls And Calibrators
3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services, Remote Monitoring Services For further insights on this market, request a sample here

North America was the largest region in the infectious disease in vitro diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, BioMérieux SA, Qiagen N.V., Becton, Dickinson and Company, Hologic, Inc., Labcorp Holdings Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Quest Diagnostics, Revvity Inc. (Formerly PerkinElmer, Inc.), OraSure Technologies, Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries, Bio-Rad Laboratories Inc., Trivitron Healthcare, and InBios International Inc. . For further insights on this market, request a sample here.

Major trends in this market include Developing Rapid Multi-Pathogen Detection Solutions To Enhance Timely Diagnosis And Expand Point-Of-Care Testing. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Infectious Disease In Vitro Diagnostics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon